Drug Information

Drug General Information
Drug ID
D0C3MW
Former ID
DIB001027
Drug Name
MBO7133
Indication Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22] Phase 1/2 [549973]
Company
Metabasis Therapeutics Inc
Target and Pathway
Target(s) Human DNA Target Info Binder [550613]
References
Ref 549973Clinical pipeline report, company report or official report of Metabasis Therapeutics (2006).
Ref 550613Novel Cox-2 Inhibitor for Breast Cancer Therapy. Temple University School of Medicine Philadelphia, Pennsylvania 19140. July 2004.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.